# Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib

> **NCT03727477** · — · COMPLETED · sponsor: **Intergroupe Francophone de Cancerologie Thoracique** · enrollment: 291 (actual)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic
- ALK Gene Rearrangement Positive
- ROS-1 Gene Rearrangement Positive

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03727477
- **Lead sponsor:** Intergroupe Francophone de Cancerologie Thoracique
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2020-10-12
- **Final completion:** 2020-10-12
- **Target enrollment:** 291 (ACTUAL)
- **Last updated:** 2023-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03727477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03727477, "Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03727477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*